Pharmaceutical Executive, Nov 1, 2007 - Pharmaceutical Executive

ADVERTISEMENT

Pharmaceutical Executive, Nov 1, 2007
Features
FDA's Approvable Problem
By Walter Armstrong
Approvable letters delay NDAs, cost pharma plenty, and are at an all-time high. Industry says FDA is gun-shy; the agency says it's business as usual. Who's right?
Rx Club Awards: Human Interest
By George Koroneos, Online Content & News Editor
With ads on topics ranging from addiction to disease states, this year's Rx Club Award winners connect creativity with emotion
Step It Up: Branding Roundtable
By Joanna Breitstein
Top pharma brand experts discuss today's issues: safety, compliance, corporate branding, combatting generics, and more.
The Intelligence Diaries
By Leonard M. Fuld
Business intelligence in a time of greater transparency is a whole new ball game. To play it well, be sure to look for surprising insights, expand your list of competitors of interest, and don't let Google be your only guide.
Celebrating Innovation: Prix Galien Photo Gallery
By Joanna Breitstein
Photos from the awards ceremony of the first US Prix Galien, September 25, 2007 in New York City.
Washington Report
More Confidence—or Slower Development?
By Jill Wechsler
FDAAA aims to restore public trust in drug safety regulation but may curb investment in R&D
From the Editor
Chasing Perfection
By Patrick Clinton
A hospital safety expert says it's now possible to completely eliminate certain adverse events. Pharma can't claim the same yet, but is it time for us to start imagining a time when we can "benchmark perfection"?
Column
The Art and Science of Effective Medical Slides
By Tammy Prouty
Most people exhibit characteristics of both visual and verbal learning styles and learn most effectively when information is presented through a combination of the two
From 3-D to Pop-ups: Go Dimensional
By Mike Maguire
In this age of new media, social networking, blogs, and cyber-clutter, it's easy to forget the appeal of the real—of things that you can hold in your hand and engage with physically. But make no mistake, despite all of the high-tech tools available to us, advertising still relies on evoking an emotional response by tickling the human senses.
Reach KOLs Online
By Alain Eudaric, Parexel Medical Communications; Mike Gauthier, eTractions , Mike Gauthier
The impact of high-quality online training tools would be difficult and costly to replicate offline given the dynamic and interactive aspects offered
Thought Leader
Preemption Preview: Q&A with Mark Herrmann, Jones Day
Leadership
Welcome Some Disruption in Your Life
By Sander A. Flaum
We have nothing to fear but the fear of change (with apologies to the wise Franklin D. Roosevelt). But we must get over that if we hope to make a real difference.
Global Report
India vs. China
By Sarah Houlton
Will CROs continue to operate in India, or will Novartis' pullout send them farther East?

ADVERTISEMENT

Click here